Characterising the HLA-I Immunopeptidome of plasma-derived extracellular vesicles in patients with melanoma

Caitlin M. Boyne, Abigail Coote, Silvia A. Synowsky, Aaron B. Naden, Sally L. Shirran, Simon J. Powis*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Downloads (Pure)

Abstract

Extracellular vesicles (EVs) frequently express human leukocyte antigen class I (HLA-I) molecules. The immunopeptidomes presented on EV HLA-I are being mapped to provide key information on both specific cancer-related peptides, and for larger immunopeptidomic signatures associated with disease. Utilizing HLA-I immunoisolation and mass spectrometry, we characterised the HLA-I immunopeptidome of EVs derived from the melanoma cancer cell line, ESTDAB-026, and the plasma of 12 patients diagnosed with advanced stage melanoma, alongside 11 healthy controls. The EV HLA-I immunopeptidome derived from melanoma cells features T cell epitopes with known immunogenicity and peptides derived from known tumour associated antigens (TAAs). Both T cell epitopes with known immunogenicity and peptides derived from known TAAs were also identifiable in the melanoma patient samples. Patient stratification into two distinct groups with varying immunological profiles was also observed. The data obtained in this study suggests for the first time that the HLA-I immunopeptidome of EVs derived from blood may aid in the detection of important diagnostic or prognostic biomarkers and also provide new immunotherapy targets.
Original languageEnglish
Article numbere146
Number of pages12
JournalJournal of Extracellular Biology
Volume3
Issue number3
Early online date26 Mar 2024
DOIs
Publication statusPublished - Mar 2024

Fingerprint

Dive into the research topics of 'Characterising the HLA-I Immunopeptidome of plasma-derived extracellular vesicles in patients with melanoma'. Together they form a unique fingerprint.

Cite this